Literature DB >> 2827973

Serum beta-N-acetyl hexosaminidase and bile acid levels in patients with benign and malignant biliary obstruction.

E Scapa1, B H Novis, M Loewenstein, P Thomas, N Zamcheck.   

Abstract

beta-N-Acetyl hexosaminidase (beta-NAH), a lysosomal enzyme, was measured in the plasma of 15 patients with malignant extrahepatic biliary obstruction, 14 with benign extrahepatic obstruction, and 15 with long-standing benign intrahepatic cholestasis. beta-NAH was correlated with total serum bile acid levels. The correlation was significant (P less than 0.05) for the malignant and benign intrahepatic obstructions but not for the benign extrahepatic obstructions. This is consistent with the idea that circulating high levels of bile acids in patients with long-standing biliary obstruction may cause damage to Kupffer cell membranes and to their receptors for beta-N-acetyl hexosaminidase, impeding the clearance of the enzyme from the circulation resulting in elevated serum levels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827973     DOI: 10.1007/BF01535732

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Urinary hexosaminidase in patients with lung carcinoma.

Authors:  M G Brattain; P M Kimball; J R Durant; T G Pretlow; D Smith; J Carpenter; M Marks
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

Review 2.  Endotoxins in liver disease.

Authors:  H Liehr; M Grün
Journal:  Prog Liver Dis       Date:  1979

3.  Expression of hexosaminidase isoenzymes in childhood leukemia.

Authors:  R B Ellis; N T Rapson; A D Patrick; M F Greaves
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

4.  The effects of triton WR1339 and asialo-fetuin on the hepatic uptake of circulating native and asialo-carcinoembryonic antigen.

Authors:  P Thomas; M Jones
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

5.  Selective hepatic uptake of human beta-hexosaminidase A by a specific glycoprotein recognition system on sinusoidal cells.

Authors:  C J Steer; J W Kusiak; R O Brady; E A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  beta-Hexosaminidase isozymes in human colonic carcinoma.

Authors:  M G Brattain; P M Kimball; T G Pretiow
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

7.  N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes.

Authors:  J M Miralles; J J Corrales; L C Garcia-Diez; J A Cabezas; A Reglero
Journal:  Clin Chim Acta       Date:  1982-06-03       Impact factor: 3.786

8.  Physical properties of human serum hexosaminidases A and B: studies in normal and cancer patients.

Authors:  C H Lo; D Kritchevsky
Journal:  Clin Chim Acta       Date:  1979-07-02       Impact factor: 3.786

9.  beta-Hexosaminidase in serum from patients with cirrhosis and cholestasis.

Authors:  B Hultberg; A Isaksson; L Jansson
Journal:  Enzyme       Date:  1981

10.  Beta-hexosaminidase activities and isoenzymes in normal human ovary and ovarian adenocarcinoma.

Authors:  S K Chatterjee; K Chowdhury; M Bhattacharya; J J Barlow
Journal:  Cancer       Date:  1982-01-01       Impact factor: 6.860

View more
  1 in total

1.  Role of endothelin in obstructive jaundice.

Authors:  A M Sarac; A O Aktan; H Moini; S Bilsel; E Scapa
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.